CTKB vs IT · rev $200.5M vs P/E 16, rev $6.27B
Cytek Biosciences Inc (CTKB) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
CTKB currently screens at market cap $421.8M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the CTKB and IT stock pages for the full models.
Not investment advice.